Annual Operating Expenses
$86.83 M
-$41.70 M-32.45%
December 31, 2023
Summary
- As of February 26, 2025, TSHA annual total operating expenses is $86.83 million, with the most recent change of -$41.70 million (-32.45%) on December 31, 2023.
- During the last 3 years, TSHA annual operating expenses has risen by +$43.82 million (+101.91%).
- TSHA annual operating expenses is now -49.89% below its all-time high of $173.27 million, reached on December 31, 2021.
Performance
TSHA Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$22.85 M
+$437.00 K+1.95%
September 30, 2024
Summary
- As of February 26, 2025, TSHA quarterly total operating expenses is $22.85 million, with the most recent change of +$437.00 thousand (+1.95%) on September 30, 2024.
- Over the past year, TSHA quarterly operating expenses has stayed the same.
- TSHA quarterly operating expenses is now -54.92% below its all-time high of $50.68 million, reached on September 30, 2021.
Performance
TSHA Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
TSHA Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -32.5% | 0.0% |
| 3 y3 years | +101.9% | 0.0% |
| 5 y5 years | - | 0.0% |
TSHA Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -49.9% | at low | -54.0% | +17.8% |
| 5 y | 5-year | -49.9% | +101.9% | -54.9% | +1949.2% |
| alltime | all time | -49.9% | +101.9% | -54.9% | +1949.2% |
Taysha Gene Therapies Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $22.85 M(+1.9%) |
| Jun 2024 | - | $22.41 M(-19.2%) |
| Mar 2024 | - | $27.74 M(+43.0%) |
| Dec 2023 | $86.83 M(-32.4%) | $19.40 M(-4.8%) |
| Sep 2023 | - | $20.38 M(-20.9%) |
| Jun 2023 | - | $25.78 M(+21.2%) |
| Mar 2023 | - | $21.27 M(+6.1%) |
| Dec 2022 | $128.53 M | $20.05 M(-21.2%) |
| Sep 2022 | - | $25.46 M(-23.7%) |
| Jun 2022 | - | $33.37 M(-32.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $49.65 M(-0.1%) |
| Dec 2021 | $173.27 M(+302.9%) | $49.72 M(-1.9%) |
| Sep 2021 | - | $50.68 M(+24.3%) |
| Jun 2021 | - | $40.77 M(+27.1%) |
| Mar 2021 | - | $32.09 M(+74.7%) |
| Dec 2020 | $43.00 M | - |
| Dec 2020 | - | $18.37 M(+22.1%) |
| Sep 2020 | - | $15.04 M(+275.1%) |
| Jun 2020 | - | $4.01 M(-28.2%) |
| Mar 2020 | - | $5.58 M(+400.8%) |
| Dec 2019 | - | $1.11 M |
FAQ
- What is Taysha Gene Therapies annual total operating expenses?
- What is the all time high annual operating expenses for Taysha Gene Therapies?
- What is Taysha Gene Therapies annual operating expenses year-on-year change?
- What is Taysha Gene Therapies quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Taysha Gene Therapies?
- What is Taysha Gene Therapies quarterly operating expenses year-on-year change?
What is Taysha Gene Therapies annual total operating expenses?
The current annual operating expenses of TSHA is $86.83 M
What is the all time high annual operating expenses for Taysha Gene Therapies?
Taysha Gene Therapies all-time high annual total operating expenses is $173.27 M
What is Taysha Gene Therapies annual operating expenses year-on-year change?
Over the past year, TSHA annual total operating expenses has changed by -$41.70 M (-32.45%)
What is Taysha Gene Therapies quarterly total operating expenses?
The current quarterly operating expenses of TSHA is $22.85 M
What is the all time high quarterly operating expenses for Taysha Gene Therapies?
Taysha Gene Therapies all-time high quarterly total operating expenses is $50.68 M
What is Taysha Gene Therapies quarterly operating expenses year-on-year change?
Over the past year, TSHA quarterly total operating expenses has changed by $0.00 (0.00%)